Cancer
Innovating Cancer Treatment
Friday, August 30th, 2024 - A husband-wife team of veterinary oncologists with expertise in tumor ablation devices is now part of the Purdue University College of Veterinary Medicine’s Department of Veterinary Clinical Sciences and the Evan and Sue Ann Werling Comparative Oncology Research Center.
Purdue and Akston Biosciences Sign Partnership Agreement for Dog Cancer Drug Development
Friday, August 16th, 2024 - Akston Biosciences Corporation, which is dedicated to accelerating the biologics revolution in Animal Health, and Purdue University have announced a strategic partnership to co-develop an anti-cPD-L1 monoclonal antibody (mAb) immunotherapy to treat cancer in dogs. The underlying technology was developed at the Purdue University College of Veterinary Medicine and the Purdue Institute for Cancer Research (PICR).
Study Led by Veterinary Oncologist Finds Cigarette Smoke Exposure Increases Cancer Risk in Dogs
Wednesday, July 31st, 2024 - A long-term study that tracked the health of Scottish terriers indicates cigarette smoke exposure leads to a sixfold increase in the risk of bladder cancer
From Personal Struggles to Professional Triumphs
Friday, July 26th, 2024 - Unceasingly optimistic. That’s how colleagues describe Dr. Marejka Shaevitz, clinical assistant professor of oncology in the Purdue University College of Veterinary Medicine’s Department of Veterinary Clinical Sciences and the Werling Comparative Oncology Research Center. Dr. Shaevitz, who completed a three-year residency program in comparative oncology at Purdue in 2020, returned to the College of Veterinary Medicine in February, expanding the number of medical oncology faculty in the Department Veterinary Clinical Sciences. Her story is one that involves facing difficult loss and challenging diagnoses herself – turning points in her life that led her on the path toward a career in veterinary oncology.
PVM’s Dr. Michael Childress Appointed to Named Professorship in Comparative Oncology
Friday, June 14th, 2024 - A faculty member in Purdue Veterinary Medicine’s Department of Veterinary Clinical Sciences, Dr. Michael Childress, has been appointed as the Evan and Sue Ann Werling Professor of Comparative Oncology.
AVMA Podcast Features Purdue Veterinary Oncologist and AVMA Journal Award Winner Marejka Shaevitz
Friday, May 17th, 2024 - When the AVMA wanted to share insights from a former resident turned award-winning published researcher, they called on a Purdue Veterinary Medicine faculty member, Dr. Marejka Shaevitz, clinical assistant professor of oncology in the Department of Veterinary Clinical Sciences.
Purdue Researchers Edge Closer to Delivering Personalized Medicine to Cancer Patients
Friday, February 9th, 2024 - Chemotherapy can save lives, but often a cancer patient may be resistant to their prescribed chemotherapy, which costs the patient valuable time. Chemoresistance is a topic that researchers need to understand better so that they can match the right type of chemo to the right patient, which is called personalized medicine. An unusual pairing of veterinary scientists and physicists believe their method of detecting chemoresistance could be the new standard for personalized medicine.
Study Led by Purdue Veterinary Oncologist Finds Exposure to Cigarette Smoke Increases Cancer Risk in Dogs
Friday, January 12th, 2024 - Dogs are humans’ best friends. Need to quickly locate a bomb? There’s a dog for that. Can’t see very well? There’s a dog for that. Searching for a lost hiker in the mountains or survivors in an earthquake, diagnosing illness, comforting the bereft — there are dogs for every need. They are even helping humans track down the causes of cancer. A new study led by Dr. Deborah Knapp, Distinguished Professor of Comparative Oncology, links cigarette smoke exposure to an exponentially higher rate of bladder cancer in Scottish terriers. By assessing individual dogs and studying their medical history, scientists are beginning to untangle the question of who gets cancer and why, and how best to detect, treat and prevent cancer.
Discovery Points to New Approach to Treating Liver Cancer
Friday, December 15th, 2023 - A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer patients for only two to three months. A study of the relationship between the enzyme DDX5, liver cancer and sorafenib, published in the Nature journal Cell Death & Disease, points to the potential for a more effective therapy that combines existing anti-cancer drugs with treatments that spur production of this enzyme.
VCS Professor is Involved in New Pediatric Cancer Research Center Named for Tyler Trent
Friday, October 27th, 2023 - The recently announced Tyler Trent Pediatric Cancer Research Center within the Purdue Institute for Cancer Research has a strong tie to the Purdue University College of Veterinary Medicine through a faculty member in the Department of Veterinary Clinical Sciences – Dr. Michael Childress. The new center is named in memory of the former graduate and devoted Boilermaker football fan who passed away more than four years ago from the rare bone cancer osteosarcoma. The center will be home to research to cure the disease that claimed Tyler’s life and other pediatric cancers.
